Simultaneous Injection of Propofol and Rocuronium in Inducing General Anesthesia

This study is conducted to evaluate the efficacy of simultaneous injection of propofol and rocuronium in inducing general anesthesia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anesthesia; Functional

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Hospital

Seoul, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients undergoing elective surgery requiring endotracheal intubation
ASA I, II, and III
above 20 years

Exclusion criteria

refuse to enroll
patients with risk of aspirating gastric contents
patients in whom NMBs are contraindicated
patients with predictors of difficult mask ventilation

Treatment and study plan

administration of propofol and rocuronium

Drug

compare the tidal volume applied from starting facemask ventilation under 15cmH2O of PCV for 1 minute according to administrating propofol and rocuronium simultaneously, or ordinally

Primary outcomes

mean tidal volume

Time frame: from starting facemask ventilation for 1 minute

mean tidal volume of facemask ventilation in 1 minute

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

Efficacy of Neuromuscular Blockade Before Facemask Ventilation in Inducing General Anesthesia

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Sep 1, 2017
Registry last updated: Apr 12, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed